13F filer · CIK 1418329 ↗
Ninety One UK Ltd
You are looking at Q3 2017. See the latest, Q3 2026 →
Reported value
$22.78B
+8.5% on the quarter before
Positions
308
42 new · 45 sold out
Top 10
27.5%
of the value
Est. gain
+$1.13B
on stocks held all quarter
Est. return
+6.3%
on those stocks since Q2 2017
Positions as of Sep 30, 2017, from Ninety One UK Ltd's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 47% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2017. Striped tiles are options.
Largest buys
Since Q2 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Baidu~$289.0MAdded · 0.0% → 1.3%+1,166,606 shares
- Dowdupont Inc~$288.6MNew · 0.0% → 1.3%+4,169,382 shares
- Verisign Inc~$262.2MNew · 0.0% → 1.2%+2,464,788 shares
- Dxc Technology Co~$199.6MAdded · 0.6% → 1.4%+2,324,095 shares
- Alibaba~$181.8MAdded · 2.8% → 4.0%+1,052,394 shares
- Delta Air Lines Inc~$158.0MNew · 0.0% → 0.7%+3,276,175 shares
- Planet Fitness Inc~$115.3MNew · 0.0% → 0.5%+4,273,966 shares
- Las Vegas Sands Corp~$105.0MAdded · 0.5% → 1.0%+1,637,248 shares
- Estee Lauder Cos Inc/The~$101.3MAdded · 0.0% → 0.5%+939,600 shares
- Popular Inc~$95.5MAdded · 0.2% → 0.6%+2,656,548 shares
Largest sells
Since Q2 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Dow Chemical Co/The~$264.1MSold out · 1.3% → 0.0%−4,187,904 shares
- Canadian Imperial Bank Of Comm~$261.6MCut · 1.2% → 0.1%−2,996,784 shares
- Cme Group Inc/Il~$246.4MCut · 1.5% → 0.4%−1,816,241 shares
- Verisign Inc~$231.1MSold out · 1.1% → 0.0%−2,486,365 shares
- Zimmer Holdings Inc~$185.0MCut · 1.2% → 0.2%−1,579,750 shares
- Carnival Corp~$146.3MCut · 1.5% → 0.8%−2,266,308 shares
- Colgate-Palmolive Co~$122.5MCut · 1.0% → 0.4%−1,682,014 shares
- Helmerich & Payne Inc~$116.4MSold out · 0.6% → 0.0%−2,142,957 shares
- Danaher Corp~$114.4MCut · 1.0% → 0.4%−1,333,073 shares
- Automatic Data Processing~$109.4MCut · 0.7% → 0.2%−1,001,048 shares
Holdings
As of Sep 30, 2017. Changes are in shares against Jun 30, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AlibabaADR · shares +25% · price +22.6% | 4.0% | $914.3M | +$134.9M | ||||||||
| MicrosoftCommon Stock · shares +12% · price +8.1% | 3.9% | $880.5M | +$58.9M | ||||||||
| Citigroup IncCommon Stock · shares +1.0% · price +8.8% | 3.3% | $753.5M | +$60.1M | ||||||||
| Johnson & JohnsonCommon Stock · shares +0.6% · price −1.7% | 2.9% | $661.1M | −$11.5M | ||||||||
| AlphabetCommon Stock · shares +2.1% · price +4.7% | 2.7% | $609.4M | +$27.0M | ||||||||
| Priceline Group Inc/TheCommon Stock · shares +6.0% · price −2.1% | 2.6% | $600.3M | −$12.3M | ||||||||
| PayPalCommon Stock · shares −4.8% · price +19.3% | 2.4% | $551.3M | +$89.2M | ||||||||
| Bank Of America CorpCommon Stock · shares +0.05% · price +4.5% | 2.0% | $450.6M | +$19.2M | ||||||||
| Unitedhealth Group IncCommon Stock · shares −0.5% · price +5.6% | 1.9% | $425.6M | +$22.7M | ||||||||
| Thermo Fisher Scientific IncCommon Stock · shares +28% · price +8.4% | 1.8% | $411.2M | +$25.0M | ||||||||
| Visa Inc.Common Stock · shares +1.2% · price +12.2% | 1.8% | $410.6M | +$44.2M | ||||||||
| Cigna CorpCommon Stock · shares +35% · price +11.7% | 1.5% | $345.8M | +$26.7M | ||||||||
| Pepsico IncCommon Stock · shares −1.2% · price −3.5% | 1.5% | $330.8M | −$12.1M | ||||||||
| Dxc Technology CoCommon Stock · shares +154% · price +11.9% | 1.4% | $329.4M | +$13.8M | ||||||||
| CumminsCommon Stock · shares +15% · price +3.6% | 1.4% | $325.9M | +$9.8M | ||||||||
| Bank Of New York Mellon CorpCommon Stock · shares −0.7% · price +3.9% | 1.3% | $302.2M | +$11.4M | ||||||||
| Cbs CorpCommon Stock · shares +6.9% · price −9.1% | 1.3% | $300.9M | −$28.0M | ||||||||
| BaiduADR · shares +3,282% · price +38.5% | 1.3% | $297.8M | +$2.4M | ||||||||
| Vmware IncCommon Stock · shares +0.5% · price +24.9% | 1.3% | $292.9M | +$58.1M | ||||||||
| Dowdupont IncCommon Stock · shares New | 1.3% | $288.6M | — | ||||||||
| Celgene CorpCommon Stock · shares +25% · price +12.3% | 1.2% | $284.2M | +$24.9M | ||||||||
| MetaCommon Stock · shares +2.5% · price +13.2% | 1.2% | $282.0M | +$32.0M | ||||||||
| Valero Energy CorpCommon Stock · shares −0.5% · price +14.0% | 1.2% | $280.8M | +$34.6M | ||||||||
| Moody's CorporationCommon Stock · shares +2.8% · price +14.4% | 1.2% | $277.6M | +$34.0M | ||||||||
| Lam ResearchCommon Stock · shares −0.05% · price +30.8% | 1.2% | $265.2M | +$62.5M | ||||||||
| Total · 308 positions | 100% | $22.78B | +$1.13B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2017 to Q3 2017: 264 stocks held throughout, up $1.13B (+6.3%).
- Alibaba+$134.9M+23%
- PayPal+$89.2M+19%
- Lam Research+$62.5M+31%
- Citigroup Inc+$60.1M+9%
- Microsoft+$58.9M+8%
- Philip Morris International In−$12.3M−5%
- Altria Group Inc−$20.2M−15%
- Netease Inc−$20.5M−12%
- Quest Diagnostics Inc−$20.9M−16%
- Cbs Corp−$28.0M−9%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 15, 2026 | $45.47B+2% | SEC ↗ |
| Q2 2026 | Jul 16, 2026 | $44.73B+4% | SEC ↗ |
| Q1 2026 | Apr 24, 2026 | $43.13B−8% | SEC ↗ |
| Q4 2025 | Jan 27, 2026 | $46.64B−49% | SEC ↗ |
| Q3 2025 | Oct 21, 2025 (amended) | $91.76B+115% | SEC ↗ |
| Q2 2025 | Jul 18, 2025 | $42.61B+19% | SEC ↗ |
| Q1 2025 | Apr 30, 2025 | $35.94B−4% | SEC ↗ |
| Q4 2024 | Jan 27, 2025 | $37.38B−0% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $37.47B+3% | SEC ↗ |
| Q2 2024 | Jul 22, 2024 | $36.22B+2% | SEC ↗ |
| Q1 2024 | Apr 25, 2024 | $35.61B+6% | SEC ↗ |
| Q4 2023 | Jan 31, 2024 | $33.61B+6% | SEC ↗ |
| Q3 2023 | Oct 10, 2023 | $31.62B−8% | SEC ↗ |
| Q2 2023 | Jul 19, 2023 | $34.27B+7% | SEC ↗ |
| Q1 2023 | Apr 28, 2023 | $32.10B+3% | SEC ↗ |
| Q4 2022 | Feb 7, 2023 | $31.19B+3% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $30.32B−10% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $33.63B−14% | SEC ↗ |
| Q1 2022 | May 26, 2022 | $39.26B−7% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $42.13B+8% | SEC ↗ |
| Q3 2021 | Nov 2, 2021 | $39.16B+1% | SEC ↗ |
| Q2 2021 | Aug 12, 2021 | $38.59B+10% | SEC ↗ |
| Q1 2021 | May 7, 2021 | $35.18B+8% | SEC ↗ |
| Q4 2020 | Feb 5, 2021 | $32.51B+18% | SEC ↗ |
| Q3 2020 | Nov 12, 2020 | $27.65B−2% | SEC ↗ |
| Q2 2020 | Sep 4, 2020 (amended) | $28.22B+19% | SEC ↗ |
| Q1 2020 | May 12, 2020 | $23.77B−21% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $30.15B+17% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $25.69B−2% | SEC ↗ |
| Q2 2019 | Jul 30, 2019 | $26.28B+4% | SEC ↗ |
| Q1 2019 | Apr 24, 2019 | $25.24B+9% | SEC ↗ |
| Q4 2018 | Feb 8, 2019 | $23.19B−13% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $26.80B+33% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 | $20.13B+8% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $18.67B−23% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $24.34B+7% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $22.78B+8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $21.00B+4% | SEC ↗ |
| Q1 2017 | May 12, 2017 | $20.25B+6% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 | $19.15B−7% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $20.53B+6% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $19.33B+5% | SEC ↗ |
| Q1 2016 | May 12, 2016 | $18.49B | SEC ↗ |